Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2019

View Archived Issues

The scWAT team: Fat, adipokine plays beneficial role in exercise effects

Epigenetic factors linked to ALS gene abnormality

Analytical method can wrest causality from association

AbbVie and Voyager enter global collaboration to develop vectorized antibodies

TMEM178 gene expression as a novel biomarker of asthma severity

Euglycemic ketoacidosis in SGLT2 inhibitor-treated rats requires dehydration and insulinopenia

Lusutrombopag approved in Europe for the treatment of severe thrombocytopenia in adults with CLD

Rizmoic approved by EC for the treatment of OIC in adults previously treated with a laxative

Novel double-hit pre-eclampsia mouse model mimics human clinical course of the condition

SPDEF as a novel biomarker of psychosocial stress and substance abuse

Takeda discloses new histone deacetylase 6 inhibitors

Novel rat model of bilateral subcortical band heterotopia

Dana-Farber Cancer Institute, The Broad Institute and Bayer patent PDE3A and PDA3B inhibitors

Tapinarof demonstrates safety and efficacy in phase II study in plaque psoriasis

New orexin OX1 receptor antagonists patented by Boehringer Ingelheim

Tyrosine kinase inhibitors idntified at the Korea Institute of Radiological and Medical Sciences

A*STAR synthesizes new antimicrobial peptidomimetics

SYROS data show long-term treatment with idebenone reduces rate of respiratory function loss in DMD

Dermira initiates proof-of-concept study with Qbrexza in primary palmar hyperhidrosis

NIAID initiates phase I study of Andes virus DNA vaccine to prevent hantavirus pulmonary syndrome

THEMIS study of Brilinta in patients with CAD and type 2 diabetes meets primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...